Skip to main content

Inogen Inc

corporate_fare Company Profile

Inogen Inc

INGN·NASDAQ·Industrial Applications And Services·CIK 0001294133

Inogen, Inc. is a medical technology company focused on respiratory health. The company develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs) and the Simeox® product for airway clearance treatment. Inogen, Inc. has also begun distributing the Inogen Voxi® 5 stationary oxygen concentrator and Aurora® continuous positive airway pressure (CPAP) masks in the United States. The proprietary Inogen One® and Inogen Rove® POC systems concentrate ambient air to provide supplemental oxygen 24 hours a day, seven days a week, using a battery or by plugging into an outlet. These POCs aim to reduce patient reliance on stationary oxygen concentrators and scheduled deliveries of oxygen tanks. The Simeox product is a technology-enabled mucus management device primarily for patients requiring airway clearance, such as those with bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease (COPD), or other chronic respiratory diseases. The Voxi 5 stationary oxygen concentrator provides continuous, long-term oxygen therapy for patients needing supplemental oxygen at home or in clinical settings. Aurora CPAP masks are used with a separate device to deliver CPAP therapy, mainly for treating obstructive sleep apnea (OSA). Inogen, Inc. was incorporated in Delaware on November 27, 2001. The company completed an initial public offering on February 14, 2014, and its common stock began trading on the Nasdaq Global Select Market under the ticker symbol "INGN". Inogen Europe Holding B.V., a Dutch limited liability company, was incorporated on April 13, 2017.

Inogen Inc (NASDAQ:INGN) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 20 items for INGN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for INGN spans 10-Q, 8-K, DEF 14A, PRE 14A.

Recent high-impact activity:

  • Inogen 10-Q: $10.6M Goodwill Wipeout Drives Q3 Loss to $16.2M
  • Inogen Swaps CEO, Closes Rotech Sale, Launches $20M Cost-Cut Program
  • Q3 Revenue Slips 2.4%, Adjusted Result Swings to Loss; $20M Cost Cuts and $15M Buyback Boost Announced
  • Inogen Swaps CEO, Elevates COO Andy Reding as Kevin Smith Departs
  • Inogen Secures Long-Term Supply Deal with Rotech, Expanding Oxygen Concentrator Distribution

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$348.67M
Net Income
-$22.75M
Diluted EPS
-$0.86
Op. Cash Flow
-$11.22M
Free Cash Flow
-$13.74M
Gross Profit
$154.26M
Operating Income
-$30.21M
Cash & Equivalents
$103.73M
Debt / Equity
0.00×
Net Margin
-6.5%
Shares Outstanding
27.23M sh
Source: 10-K · filed 2026-02-27 · accession 0001193125-26-082630

Short Interest & Short Volume

5.76 days to cover

FINRA reported short interest of 1,403,057 shares in INGN as of the October 30, 2026 settlement, a 8.3% decrease from the prior period — about 5.8 days to cover at its recent average daily volume. On November 20, 2026, 39.2% of INGN volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,403,057 shares as of October 30, 2026
Change vs prior period▼ 8.3%
Days to cover5.76 at avg daily volume of 243,734
Daily short volume (FINRA facilities)39.2% of 149,332 shares on November 20, 2026
5-day average short volume32.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with I →
$5.3
52-week range · as of 2026-11-09 $5.04 – $7.67
Market cap
$137.81M
Volume
351.9K (1.3× avg)
3-mo avg 281K
Live data · 2026-11-21 02:32 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed INGN - Latest Insights

INGN
Nov 09, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $6.12
Real-time Price: $5.30 info
Change: -$0.815 (-13%) info
Market Cap: $137.811M info
INGN
Nov 05, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.30
Real-time Price: $5.30 info
Change: -$0.9999 (-16%) info
Market Cap: $137.811M info
INGN
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $6.50
Real-time Price: $5.30 info
Change: -$1.20 (-18%) info
Market Cap: $137.811M info
INGN
Nov 05, 2026, 4:00 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $6.81
Real-time Price: $5.30 info
Change: -$1.51 (-22%) info
Market Cap: $137.811M info
INGN
Sep 30, 2026, 5:26 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.62
Real-time Price: $5.30 info
Change: -$0.320 (-6%) info
Market Cap: $137.811M info
INGN
Sep 30, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.27
Real-time Price: $5.30 info
Change: +$0.030 (+0.57%) info
Market Cap: $137.811M info
INGN
Aug 07, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $6.05
Real-time Price: $5.30 info
Change: -$0.750 (-12%) info
Market Cap: $137.811M info
INGN
Aug 06, 2026, 4:45 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $6.10
Real-time Price: $5.30 info
Change: -$0.800 (-13%) info
Market Cap: $137.811M info
INGN
Aug 06, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.38
Real-time Price: $5.30 info
Change: -$1.08 (-17%) info
Market Cap: $137.811M info
INGN
Jul 01, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.70
Real-time Price: $5.30 info
Change: -$1.40 (-21%) info
Market Cap: $137.811M info
INGN
Jun 11, 2026, 4:32 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.13
Real-time Price: $5.30 info
Change: -$0.830 (-14%) info
Market Cap: $137.811M info
INGN
May 08, 2026, 4:10 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $7.02
Real-time Price: $5.30 info
Change: -$1.72 (-25%) info
Market Cap: $137.811M info
INGN
May 07, 2026, 4:47 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $7.05
Real-time Price: $5.30 info
Change: -$1.75 (-25%) info
Market Cap: $137.811M info
INGN
May 07, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $7.05
Real-time Price: $5.30 info
Change: -$1.75 (-25%) info
Market Cap: $137.811M info
INGN
Apr 28, 2026, 4:09 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $7.35
Real-time Price: $5.30 info
Change: -$2.05 (-28%) info
Market Cap: $137.811M info
INGN
Apr 17, 2026, 4:06 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $6.82
Real-time Price: $5.30 info
Change: -$1.52 (-22%) info
Market Cap: $137.811M info
INGN
Apr 06, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.36
Real-time Price: $5.30 info
Change: -$1.06 (-17%) info
Market Cap: $137.811M info
INGN
Mar 30, 2026, 5:32 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.11
Real-time Price: $5.30 info
Change: -$0.810 (-13%) info
Market Cap: $137.811M info
INGN
Feb 27, 2026, 4:12 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $6.10
Real-time Price: $5.30 info
Change: -$0.800 (-13%) info
Market Cap: $137.811M info
INGN
Feb 24, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $6.22
Real-time Price: $5.30 info
Change: -$0.920 (-15%) info
Market Cap: $137.811M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets